DD289263A5 - Verfahren zur herstellung von diaryl-verbindungen - Google Patents

Verfahren zur herstellung von diaryl-verbindungen Download PDF

Info

Publication number
DD289263A5
DD289263A5 DD89334709A DD33470989A DD289263A5 DD 289263 A5 DD289263 A5 DD 289263A5 DD 89334709 A DD89334709 A DD 89334709A DD 33470989 A DD33470989 A DD 33470989A DD 289263 A5 DD289263 A5 DD 289263A5
Authority
DD
German Democratic Republic
Prior art keywords
formula
compound
phenyl
hydrogen
physiologically
Prior art date
Application number
DD89334709A
Other languages
German (de)
English (en)
Inventor
William P Jackson
Clifford J Harris
Richard J Arrowsmith
John G Dann
Kevin J O'connor
Robert F G Booth
Original Assignee
��������@��������@����������@���k��
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ��������@��������@����������@���k�� filed Critical ��������@��������@����������@���k��
Publication of DD289263A5 publication Critical patent/DD289263A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/04—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms
    • C07C275/20—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an unsaturated carbon skeleton
    • C07C275/24—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing six-membered aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/02—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C07C233/04—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C233/07—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/02—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C07C233/11—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to carbon atoms of an unsaturated carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/40—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/40—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings
    • C07C271/42—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/44—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C275/30—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by halogen atoms, or by nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/28—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to cyano groups, e.g. cyanoguanidines, dicyandiamides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C327/00—Thiocarboxylic acids
    • C07C327/38—Amides of thiocarboxylic acids
    • C07C327/40—Amides of thiocarboxylic acids having carbon atoms of thiocarboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C327/44—Amides of thiocarboxylic acids having carbon atoms of thiocarboxamide groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of an unsaturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
  • Eye Examination Apparatus (AREA)
  • Polarising Elements (AREA)
  • Prostheses (AREA)
DD89334709A 1988-11-21 1989-11-20 Verfahren zur herstellung von diaryl-verbindungen DD289263A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888827152A GB8827152D0 (en) 1988-11-21 1988-11-21 Anti-atherosclerotic diaryl compounds

Publications (1)

Publication Number Publication Date
DD289263A5 true DD289263A5 (de) 1991-04-25

Family

ID=10647180

Family Applications (1)

Application Number Title Priority Date Filing Date
DD89334709A DD289263A5 (de) 1988-11-21 1989-11-20 Verfahren zur herstellung von diaryl-verbindungen

Country Status (27)

Country Link
EP (2) EP0370740B1 (el)
JP (1) JPH02188568A (el)
KR (1) KR900007790A (el)
AT (2) ATE78812T1 (el)
AU (1) AU638950B2 (el)
CA (1) CA2003395A1 (el)
CZ (1) CZ277693B6 (el)
DD (1) DD289263A5 (el)
DE (2) DE68913762T2 (el)
DK (1) DK581889A (el)
ES (2) ES2062610T3 (el)
FI (1) FI895520A0 (el)
GB (1) GB8827152D0 (el)
GR (1) GR3006091T3 (el)
HU (1) HU205342B (el)
IE (2) IE940341L (el)
IL (1) IL92358A (el)
LT (1) LTIP418A (el)
MX (1) MX9203417A (el)
MY (1) MY106247A (el)
NO (1) NO172233C (el)
NZ (1) NZ231448A (el)
PL (1) PL162010B1 (el)
PT (2) PT92354A (el)
RU (1) RU2036901C1 (el)
TW (1) TW213445B (el)
ZA (1) ZA898842B (el)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ229828A (en) * 1988-08-09 1992-03-26 Squibb & Sons Inc Aryl cyanoguanidine derivatives and pharmaceutical compositions
US5290814A (en) * 1988-11-21 1994-03-01 Burroughs Wellcome Co. Anti-atherosclerotic diaryl compounds
GB9020841D0 (en) * 1990-09-25 1990-11-07 Wellcome Found Anti-atherosclerotic aryl compounds
GB9027023D0 (en) * 1990-12-12 1991-01-30 Wellcome Found Anti-atherosclerotic aryl compounds
IL100915A (en) * 1991-02-19 1996-03-31 Erba Carlo Spa Double-transformed urea and theories, their preparation and pharmaceutical preparations containing them
US5310748A (en) * 1992-05-11 1994-05-10 The Du Pont Merck Pharmaceutical Company Imidazoles for the treatment of atherosclerosis
US5364875A (en) * 1992-05-11 1994-11-15 The Du Pont Merck Pharmaceutical Company Imidazoles linked to bicyclic heterocyclic groups for the treatment of atherosclerosis
CA2123728A1 (en) * 1993-05-21 1994-11-22 Noriyoshi Sueda Urea derivatives and their use as acat inhibitors
WO1995001326A1 (en) * 1993-06-30 1995-01-12 The Wellcome Foundation Limited Anti-atherosclerotic diaryl compounds
NZ264063A (en) * 1993-08-13 1995-11-27 Nihon Nohyaku Co Ltd N-(2-phenylpyrid-3-yl)- and n-(4-phenylpyrimidin-5-yl)-n'-phenylurea derivatives and pharmaceutical compositions
US5547966A (en) * 1993-10-07 1996-08-20 Bristol-Myers Squibb Company Aryl urea and related compounds
US5576335A (en) * 1994-02-01 1996-11-19 Nisshin Flour Milling Co., Ltd. Urea derivatives and their use as ACAT inhibitors
US5491152A (en) * 1994-03-23 1996-02-13 The Du Pont Merck Pharmaceutical Company Derivatives of cyclic ethers and sulfides for the treatment of atherosclerosis
KR970706242A (ko) * 1994-10-04 1997-11-03 후지야마 아키라 우레아 유도체 및 ACAT-억제제로서 그의 용도(Urea derivatives and their use as ACAT-inhibitors)
EP0742208A1 (en) * 1995-05-05 1996-11-13 Grelan Pharmaceutical Co., Ltd. 2-Ureido-benzamide derivatives
US5866609A (en) * 1996-08-09 1999-02-02 Ss Pharmaceutical Co., Ltd. Substituted vinylurea derivatives and medicine containing the same
FR2946342B1 (fr) 2009-06-05 2011-06-24 Galderma Res & Dev Nouveaux derives de dioxo-imidazolidine, inhibiteurs de l'enzyme soat-1, compositions pharmaceutiques et cosmetiques les contenant.
FR2946340B1 (fr) 2009-06-05 2011-06-24 Galderma Res & Dev Nouveaux n-phenyl acetamie, inhibiteurs de l'enzyme soat-1, compositions pharmaceutiques et cosmetiques les contenant.
FR2946346B1 (fr) 2009-06-05 2011-05-20 Galderma Res & Dev Nouveaux derives dioxo-imidazolidine, inhibiteurs de l'enzyme soat-1, compositions pharmaceutiques et cosmetiques les contenant.
FR2946345B1 (fr) 2009-06-05 2011-05-20 Galderma Res & Dev Nouveaux derives dioxo-imidazolidine, inhibiteurs de l'enzyme soat-1, compositions pharmaceutiques et cosmetiques les contenant.

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4029786A (en) * 1972-08-11 1977-06-14 Imperial Chemical Industries Limited Morpholine derivatives for treating depression
GB1382526A (en) * 1972-08-11 1975-02-05 Ici Ltd Morpholine derivatives
ZA801680B (en) * 1979-04-03 1981-03-25 Fujisawa Pharmaceutical Co 2-imidazoline derivatives,process for the preparation thereof and the pharmaceutical composition of the same
US4269829A (en) * 1979-06-18 1981-05-26 Rohm And Haas Company Method and composition for treating helminths containing O,O-dialkyl-N-(substituted phenyl)aminothiocarbonyl phosphoramidates
US4387106A (en) * 1982-01-26 1983-06-07 American Cyanamid Company Method of treating atherosclerosis with di(aralkyl)ureas and di(aralkyl)thioureas
JPS60500176A (ja) * 1982-12-30 1985-02-07 ビ−チヤム　グル−プ　ピ−エルシ− 四環式化合物
US4603145A (en) * 1983-05-06 1986-07-29 American Cyanamid Company Antiatherosclerotic diphenyl alkanamides
US4716175A (en) * 1987-02-24 1987-12-29 Warner-Lambert Company Saturated fatty acid amides as inhibitors of acyl-CoA:cholesterol acyltransferase
JPH0193569A (ja) * 1987-07-02 1989-04-12 Warner Lambert Co アシル‐ＣｏＡ：コレステロールアシルトランスフエラーゼのＮ‐〔（２，６‐ジ置換）フエニル〕尿素およびカルバメート阻害剤

Also Published As

Publication number Publication date
MX9203417A (es) 1992-07-01
EP0370740A1 (en) 1990-05-30
RU2036901C1 (ru) 1995-06-09
IE893700L (en) 1990-05-21
CS655889A3 (en) 1992-11-18
ZA898842B (en) 1991-07-31
CA2003395A1 (en) 1990-05-21
NO172233B (no) 1993-03-15
AU4536389A (en) 1990-05-24
CZ277693B6 (en) 1993-03-17
ATE102604T1 (de) 1994-03-15
PT101725B (pt) 1997-08-29
ES2052028T3 (es) 1994-07-01
DK581889D0 (da) 1989-11-20
MY106247A (en) 1995-04-29
IL92358A0 (en) 1990-07-26
GB8827152D0 (en) 1988-12-29
KR900007790A (ko) 1990-06-02
DK581889A (da) 1990-05-22
NO894616D0 (no) 1989-11-20
LTIP418A (en) 1994-09-25
IE940341L (en) 1990-05-21
EP0450660A1 (en) 1991-10-09
DE68913762T2 (de) 1994-06-23
DE68913762D1 (de) 1994-04-14
AU638950B2 (en) 1993-07-15
DE68902301T2 (de) 1993-02-25
EP0450660B1 (en) 1994-03-09
FI895520A0 (fi) 1989-11-20
NZ231448A (en) 1992-03-26
PL162010B1 (pl) 1993-08-31
ATE78812T1 (de) 1992-08-15
TW213445B (el) 1993-09-21
IE65411B1 (en) 1995-10-18
IL92358A (en) 1994-06-24
HU205342B (en) 1992-04-28
DE68902301D1 (de) 1992-09-03
JPH02188568A (ja) 1990-07-24
EP0370740B1 (en) 1992-07-29
GR3006091T3 (el) 1993-06-21
PT92354A (pt) 1990-05-31
ES2062610T3 (es) 1994-12-16
NO894616L (no) 1990-05-22
PT101725A (pt) 1996-01-31
NO172233C (no) 1993-06-23
HUT52040A (en) 1990-06-28

Similar Documents

Publication Publication Date Title
DD289263A5 (de) Verfahren zur herstellung von diaryl-verbindungen
DE69133299T2 (de) Aminosulfonylcarbamate
EP0600949B1 (de) Neue 3,5-di-tert.butyl-4-hydroxyphenyl-derivate, verfahren zu ihrer herstellung und arzneimittel
DE69531098T2 (de) Piperidine und pyrrolidine
DE3320521A1 (de) Heterocyclische verbindungen, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
EP0022958A1 (de) Harnstoffderivate zur Verwendung bei der Behandlung von Fettstoffwechselstörungen
DE69936397T2 (de) 3,4-disubstituierte acylanilidderivate und deren verwendung als androgen rezeptor suppressoren
DE2758025A1 (de) Neue derivate von 3,4,5-trihydroxypiperidin, verfahren zu ihrer herstellung und ihre verwendung
DE3005580C2 (el)
JPH07300417A (ja) 抗うつまたは抗パーキンソン病薬
US5290814A (en) Anti-atherosclerotic diaryl compounds
US2964560A (en) Orally effective compounds for treating diabetes and a process of making same
EP0008715B1 (de) Phenyläthanolamine zur Verwendung bei der Bekämpfung von entzündlichen Zuständen
US3896235A (en) Anthelmintic ethers and composition thereof
EP0006217B1 (de) Substituierte Aminoalkansäuren, ihre Verwendung und Herstellung und sie enthaltende Arzneimittel
DE2030686C3 (de) Substituierte N-Phenacylcarbamate
EP0006218B1 (de) Substituierte Aminosäuren, ihre Verwendung und Herstellung und sie enthaltende Arzneimittel
DE1937759A1 (de) Benzolsulfonylsemicarbazide und Verfahren zu ihrer Herstellung
EP0105393B1 (de) Neue Nucleosidverbindungen, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel
DE2817112C2 (el)
DE2242375C3 (de) 1,4-Disubstituierte 6-Nitro-2(1 H(-chinazolinone
AT361501B (de) Verfahren zur herstellung von neuen n-methyl-n' -acylaminoaethylbenzolsulfonylharnstoffen
DE2618547A1 (de) Oxazolderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische mittel
EP1596856B1 (de) Arzneimittel enthaltend substituierte 2-aryl-aminoessigsäure-verbindungen und/oder substituierte 2-heteroaryl-aminoessigsäure-verbindungen
CH374984A (de) Verfahren zur Herstellung von Benzolsulfonylharnstoffen

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee